Disentangling the relationship between biological age and frailty in community-dwelling older Mexican adults - Fermín-Martínez, Carlos A.; Ramírez-García, Daniel; Antonio-Villa, Neftali Eduardo; López-Teros, Miriam Teresa; Seiglie, Jacqueline A.; Castrejón Pérez, Roberto Carlos; García Peña, Carmen; Gutiérrez-Robledo, Luis Miguel; Bello-Chavolla, Omar Yaxmehen (medRxiv, 2024)
OBJECTIVE Older adults have heterogeneous aging rates. Here, we explored the impact of biological age (BA) and accelerated aging on frailty in community-dwelling older adults.METHODS We assessed 735 community-dwelling older adults from the Coyocan Cohort. BA was measured using AnthropoAge, accelerated aging with AnthropoAgeAccel, and frailty using both Fried’s phenotype and the frailty index. We explored the association of BA and accelerated aging (AnthropoAgeAccel >=0) with frailty at baseline and characterized the impact of both on body composition and physical function. We also explored accelerated aging as a risk factor for frailty progression after 3-years of follow-up.RESULTS Older adults with accelerated aging have higher frailty prevalence and indices, lower handgrip strength and gait speed. AnthropoAgeAccel was associated with higher frailty indices (β=0.0053, 95%CI 0.0027-0.0079), and increased odds of frailty at baseline (OR 1.16, 95%CI 1.09-1.25). We observed a sexual dimorphism in body composition and physical function linked to accelerated aging in non-frail participants; however, this dimorphism was absent in pre-frail/frail participants. Accelerated aging at baseline was associated with higher risk of frailty progression over time (OR 1.74, 95%CI 1.11-2.75).CONCLUSIONS Despite being intertwined, biological accelerated aging is largely independent of frailty in community-dwelling older adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data collection procedures were approved by the Ethics Committee of the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll code and materials are available for reproducibility of results at https://github.com/oyaxbell/anthropoage_frailty/